Advertisement
BridgeBio Pharma, Inc.

BridgeBio Pharma, Inc. (BBIO) Stock Overview

Explore BridgeBio Pharma, Inc.’s financial performance, market position, analyst ratings, and future outlook.

BBIO●NASDAQ
HealthcareBiotechnology
$67.33
$1.85(2.83%)
U.S. Market opens in 14h 49m
Advertisement

BridgeBio Pharma, Inc. (BBIO)

Meyka AI Score

Z

Key Financials

Market Cap13.2B
P/E Ratio-18.13
EPS (TTM)$-3.74
ROE0.36%
Fundamental Analysis

AI Price Forecasts

1 Month$64.32
3 Months$80.14
1 Year Target$73.29

BBIO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BridgeBio Pharma, Inc. (BBIO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 43.61, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $73.29.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -18.13 and a market capitalization of 13.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.83%
5-Day Change
-0.93%
1-Month Change
-2.41%
3-Month Change
1.19%
6-Month Change
-9.94%
Year-to-Date (YTD) Change
-11.98%
1-Year Change
77.09%
3-Year Change
361.16%
5-Year Change
16.17%
All-Time (Max) Change
144.39%

Contact Information

https://www.bridgebio.com
650 391 9740
421 Kipling Street, Palo Alto, CA, 94301

Company Facts

725 Employees
IPO DateJun 27, 2019
CountryUS
Actively Trading

Frequently Asked Questions